Cited by

• Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID).

  Dougados M, Brault Y, Logeart I, van der Heijde D, Gossec L, Kvien T. Dougados M, et al. Arthritis Res Ther. 2012 May 30;14(3):R129. doi: 10.1186/ar3859. Arthritis Res Ther. 2012. PMID: 22647431 Free PMC article. Clinical Trial.
• Comparing the effect of eye movement desensitization and reprocessing (EMDR) with guided imagery on pain severity in patients with rheumatoid arthritis.

  Nia NG, Afrasiabifar A, Behnammoghadam M. Nia NG, et al. J Pain Res. 2018 Sep 28;11:2107-2113. doi: 10.2147/JPR.S158981. eCollection 2018. J Pain Res. 2018. PMID: 30319285 Free PMC article.
• Patterns of background factors related to early RA patients' conceptions of the cause of their disease.

  Bergsten U, Bergman S, Fridlund B, Alfredsson L, Berglund A, Arvidsson B, Petersson IF; EIRA study group. Bergsten U, et al. Clin Rheumatol. 2011 Mar;30(3):347-52. doi: 10.1007/s10067-010-1556-6. Epub 2010 Aug 24. Clin Rheumatol. 2011. PMID: 20734214
• Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis.

  Nishiyama S, Aita T, Yoshinaga Y, Kishimoto H, Toda M, Yoshihara Y, Miyoshi S, Manki A, Miyawaki S. Nishiyama S, et al. Rheumatol Int. 2012 Aug;32(8):2569-71. doi: 10.1007/s00296-011-2058-9. Epub 2011 Jul 26. Rheumatol Int. 2012. PMID: 21789609
• Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data.

  Dougados M, Schmidely N, Le Bars M, Lafosse C, Schiff M, Smolen JS, Aletaha D, van Riel P, Wells G. Dougados M, et al. Ann Rheum Dis. 2009 Apr;68(4):484-9. doi: 10.1136/ard.2008.092577. Epub 2008 Dec 11. Ann Rheum Dis. 2009. PMID: 19074177 Free PMC article. Clinical Trial.